Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.
about
Current and Future Theranostic Applications of the Lipid-Calcium-Phosphate Nanoparticle Platform.Calcium Phosphate as a Key Material for Socially Responsible Tissue Engineering.Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis.Biocompatible and colloidally stabilized mPEG-PE/calcium phosphate hybrid nanoparticles loaded with siRNAs targeting tumors.The Role of Hydroxyl Channel in Defining Selected Physicochemical Peculiarities Exhibited by Hydroxyapatite.Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formationGlutamine-chitosan modified calcium phosphate nanoparticles for efficient siRNA delivery and osteogenic differentiation.Uptake of the proteins HTRA1 and HTRA2 by cells mediated by calcium phosphate nanoparticlesDelivery of the autofluorescent protein R-phycoerythrin by calcium phosphate nanoparticles into four different eukaryotic cell lines (HeLa, HEK293T, MG-63, MC3T3): Highly efficient, but leading to endolysosomal proteolysis in HeLa and MC3T3 cells.Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cellsProgress and perspective of inorganic nanoparticle-based siRNA delivery systemsLipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing.Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicinesDelivering Nucleic-Acid Based Nanomedicines on Biomaterial Scaffolds for Orthopedic Tissue Repair: Challenges, Progress and Future Perspectives.Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.Recent developments in polydopamine: an emerging soft matter for surface modification and biomedical applications.Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.Mechanistic Insight into Receptor-Mediated Delivery of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantamethamidyl Host:Guest pDNA Nanoparticles to CD44(+) Cells.Calcium-based biomaterials for diagnosis, treatment, and theranostics.Coordination-driven assembly of catechol-modified chitosan for the kidney-specific delivery of salvianolic acid B to treat renal fibrosis.Polysaccharides for the Delivery of Antitumor Drugs.Systemic delivery of siRNA by hyaluronan-functionalized calcium phosphate nanoparticles for tumor-targeted therapy.
P2860
Q26746186-A5857943-F0B1-4125-AEA5-F749BB86CC54Q30376710-0B705F3A-396F-4211-8F06-43BB782BE4F3Q31164958-FAE422DD-7138-45A2-A7CE-4EA79D8E0AB3Q35857347-85912A04-79DA-4F8D-91BD-47969D1C4042Q35897293-DA7619E1-17E5-478D-AA19-19D7F9F7A9A5Q35995453-77E2476D-6977-403A-BD9B-9250916BE11CQ36092151-B267532B-3E5C-45C1-ABD2-2E9F99CFBAFCQ36317174-0646BE40-3B22-41A0-BF06-D524FFA0531CQ36393940-B1CFB1C1-BE60-4ED1-B363-C4D17FAD9C57Q36907352-9ED08277-49BD-4C55-87D4-C67CE13E5A41Q37021426-6119A4E6-53CA-4B66-9C10-3B7A99141FB5Q38663657-CFF1E396-337B-4348-BFD9-11FB94EDF1CDQ38674444-CD0D251B-28FB-419C-8B4A-40273641E850Q38912667-83F840ED-7531-4101-B8C5-AEC43A8415C7Q38928173-6C4C372F-3876-4A98-BB4F-1E829A001ACCQ38972392-DDF33A10-A1CB-454D-9E20-924A356F4418Q39317565-5C84994D-1EE6-4557-A8F3-CD6A31ED6D8BQ39979713-90D15E6C-00F4-4E60-BD3A-12253967A1B0Q47231934-43731945-1C72-4E2C-8239-131C1491A017Q47369136-B08AA7F6-228B-4F70-8BF9-4644B8E0562EQ50347968-C1E2991D-270A-45A6-A3CA-39D3F1179463Q50796407-4A3B7820-39C3-40BE-BB1A-DB055179AAE7
P2860
Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Target-specific delivery of si ...... opa-hyaluronic acid conjugate.
@en
type
label
Target-specific delivery of si ...... opa-hyaluronic acid conjugate.
@en
prefLabel
Target-specific delivery of si ...... opa-hyaluronic acid conjugate.
@en
P2093
P1476
Target-specific delivery of si ...... opa-hyaluronic acid conjugate.
@en
P2093
Doo Sung Lee
Eunkyoung Byun
Haeshin Lee
Ji Hoon Jeong
Jung Eun Lee
Min Sang Lee
Nak Won Kim
Sang Jun Sim
P304
P356
10.1016/J.JCONREL.2014.06.049
P407
P577
2014-07-01T00:00:00Z